CA
Carisma Therapeutics, Inc.
CARM · OTC
$0.00 +0.00% (+$0.00)
1M -65.22%
Market Cap $33.5K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E 0.00x
P/FFO N/A
Growth
0 /100
Declining Rev. growth 9.57%
Book val. growth N/A
EPS growth N/A
Profitability
63 /100
Moderate Op. margin 20.61%
Gross margin 98.05%
FCF margin 42.59%
Quality
43 /100
Average Asset turnover 8.03x
ROIC 10,330.50%
ROA 122.70%
Debt
79 /100
Low Net debt/EBITDA -0.15x
Current ratio 0.86x
Debt/Assets N/A
Stability
13 /100
Unstable EPS volatility 2,319.95%
Beta -9.03x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CARM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
46
Headquarters
Philadelphia
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report